1st Quarter - Report

W STRATEGIES, LLC for CALIFORNIA LIFE SCIENCES

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Promoted life sciences community and communicated economic and health benefits of the industry.

LobbyistCovered position, as disclosed
DARREN WILLCOX —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Budget/Appropriations BUD

H.R.1892: Bipartisan Budget Act of 2018 as it relates to a Part D donut hole provision and IPAB repeal. H.R.1625: Consolidated Appropriations Act, 2018.

LobbyistCovered position, as disclosed
DARREN WILLCOX —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1892 (115th), H.R. 1625 (115th)

Medicare/Medicaid MMM

H.R.849/H.J.Res 51: IPAB Repeal Act and Joint Resolution related to IPAB Repeal.

LobbyistCovered position, as disclosed
DARREN WILLCOX —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 849 (115th), H.J.Res. 51 (115th)

Taxation/Internal Revenue Code TAX

H.R. 184: Protect Medical Innovation Act. FY 2018 Continuing resolution as it relates to suspension of the medical device tax.

LobbyistCovered position, as disclosed
DARREN WILLCOX —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 184 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.